Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Marith I. Francke"'
Autor:
Marith I. Francke, BSc, Marian C. Clahsen-van Groningen, MD, PhD, Thierry P. P. van den Bosch, PhD, Jan U. Becker, MD, PhD, Dennis A. Hesselink, MD, PhD
Publikováno v:
Transplantation Direct, Vol 7, Iss 7, p e717 (2021)
Background. Cholesterol embolization syndrome (CES) is an uncommon but well-known cause of renal failure in native kidneys, but little is known about CES in kidney transplant recipients. The aim of this study was to determine the incidence, clinical
Externí odkaz:
https://doaj.org/article/5ae0cc1c09cb4cd2aaddd133876cda02
Autor:
Suwasin Udomkarnjananun, Marith I. Francke, Marjolein Dieterich, Daan van De Velde, Nicolle H.R. Litjens, Karin Boer, Brenda C.M. De Winter, Carla C. Baan, Dennis A. Hesselink
Publikováno v:
Transplantation, 107(2), 382-391. Lippincott Williams & Wilkins
Background. Transplant recipients may develop rejection despite having adequate tacrolimus whole blood predose concentrations (C0). The intra-immune cellular concentration is potentially a better target than C0. However, little is known regarding int
Autor:
Suwasin Udomkarnjananun, Marith I. Francke, Marjolein Dieterich, Daan van de Velde, Jeroen G. H. P. Verhoeven, Karin Boer, Marian C. Clahsen-Van Groningen, Brenda C. M. De Winter, Carla C. Baan, Dennis A. Hesselink
Publikováno v:
Therapeutic Drug Monitoring, 44(5), 625-632. Lippincott Williams & Wilkins
Background:Intracellular tacrolimus concentration in peripheral blood mononuclear cells (PBMCs) (TAC [PBMC]) has been proposed to better represent its active concentration than its whole blood concentration. As tacrolimus acts on T lymphocytes and ot
Autor:
Linda G. Franken, Marith I. Francke, Louise M. Andrews, Ron H. N. van Schaik, Yi Li, Lucia E. A. de Wit, Carla C. Baan, Dennis A. Hesselink, Brenda C. M de Winter
Publikováno v:
European Journal of Drug Metabolism and Pharmacokinetics, 47(4), 523-535. Springer Paris
Background and Objective: The tacrolimus concentration within peripheral blood mononuclear cells may correlate better with clinical outcomes after transplantation compared to concentrations measured in whole blood. However, intracellular tacrolimus m
Autor:
Marith I. Francke, Bart van Domburg, Daan van de Velde, Dennis A. Hesselink, Brenda C.M. de Winter
Publikováno v:
Clinical Biochemistry, 104, 70-73. Elsevier Inc.
Dried blood spot (DBS) microsampling has several advantages over venous blood sampling. In a clinical validation study of tacrolimus microsampling it was noted that tacrolimus DBS concentrations ([Tac]DBS) were systematically higher than tacrolimus w
Autor:
Marith I. Francke, Bart van Domburg, Samah Bouarfa, Daan van de Velde, Merel E. Hellemons, Olivier C. Manintveld, Suzanne Last-Koopmans, Midas B. Mulder, Dennis A. Hesselink, Brenda C.M. de Winter
Publikováno v:
Clinica Chimica Acta, 535, 131-139. Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82531b71bf7b876a3fb07a374ab813fb
https://pure.eur.nl/en/publications/9037566b-760f-4f57-81c8-464c789ca73e
https://pure.eur.nl/en/publications/9037566b-760f-4f57-81c8-464c789ca73e
Autor:
Marith I. Francke, Laura E. J. Peeters, Dennis A. Hesselink, Sanne M. Kloosterboer, Birgit C. P. Koch, Herman Veenhof, Brenda C. M. de Winter
Publikováno v:
Therapeutic Drug Monitoring, 44(5), 696-700. LIPPINCOTT WILLIAMS & WILKINS
Therapeutic Drug Monitoring, 44(5), 696-700. Lippincott Williams & Wilkins
Therapeutic Drug Monitoring, 44(5), 696-700. Lippincott Williams & Wilkins
BACKGROUND: Sampling of blood at home to determine the concentration of drugs or other compounds can be effective in limiting hospital-based sampling. This could lower hospital visits and patient burden, improve the quality of life, and reduce health
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd4b5f4b2672cd75a3157268eabe7a5e
https://research.rug.nl/en/publications/daa2af3a-2498-4ee7-bf91-23acfcc991c3
https://research.rug.nl/en/publications/daa2af3a-2498-4ee7-bf91-23acfcc991c3
Autor:
Suwasin, Udomkarnjananun, Marith I, Francke, Marjolein, Dieterich, Daan, van De Velde, Nicolle H R, Litjens, Karin, Boer, Brenda C M, De Winter, Carla C, Baan, Dennis A, Hesselink
Publikováno v:
Transplantation.
Transplant recipients may develop rejection despite having adequate tacrolimus whole blood predose concentrations (C0). The intra-immune cellular concentration is potentially a better target than C0. However, little is known regarding intracellular t
Autor:
Dennis A. Hesselink, Louise M. Andrews, Marian C. Clahsen-van Groningen, Brenda C. M. de Winter, Teun van Gelder, Jacqueline van de Wetering, Bronno van der Holt, Ron H.N. van Schaik, Marith I. Francke, Hoang Lan Le
Publikováno v:
Clinical Pharmacology and Therapeutics
Clinical Pharmacology and Therapeutics, 110(1), 169-178. Wiley-Blackwell
Clinical Pharmacology and Therapeutics, 110(1), 169-178. WILEY
Clinical Pharmacology and Therapeutics, 110(1), 169-178. Wiley-Blackwell
Clinical Pharmacology and Therapeutics, 110(1), 169-178. WILEY
Bodyweight-based tacrolimus dosing followed by therapeutic drug monitoring is standard clinical care after renal transplantation. However, after transplantation, a meager 38% of patients are on target at first steady-state and it can take up to 3 wee
Autor:
Brenda C. M. de Winter, Dennis A. Hesselink, Yi Li, Ron H.N. van Schaik, Lin Yang, Birgit C. P. Koch, Marith I. Francke, Teun van Gelder, Carla C. Baan, Lucia E.A. de Wit
Publikováno v:
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, 87(4), 1918-1929. Wiley-Blackwell Publishing Ltd
British Journal of Clinical Pharmacology, 87(4), 1918-1929. Wiley-Blackwell Publishing Ltd
Aims: Tacrolimus is a critical dose drug and to avoid under- and overexposure, therapeutic drug monitoring is standard practice. However, rejection and drug-related toxicity occur despite whole-blood tacrolimus pre-dose concentrations ([Tac]blood) be